Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma.
Saved in:
| Title: | Enhanced triacylglycerol catabolism by carboxylesterase 1 promotes aggressive colorectal carcinoma. |
|---|---|
| Authors: | Capece D; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.; Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L'Aquila, L'Aquila, Italy., D'Andrea D; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Begalli F; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Goracci L; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy., Tornatore L; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Alexander JL; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom., Di Veroli A; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy., Leow SC; Singapore Institute for Clinical Sciences (SICS), and., Vaiyapuri TS; Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore., Ellis JK; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Verzella D; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Bennett J; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom., Savino L; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.; Department of Medical, Oral, and Biotechnological Sciences, 'G. D'Annunzio' University of Chieti-Pescara, Chieti, Italy., Ma Y; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom., McKenzie JS; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Doria ML; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Mason SE; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Chng KR; Genome Institute of Singapore, Singapore., Keun HC; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Frost G; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, United Kingdom., Tergaonkar V; Institute of Molecular and Cell Biology (IMCB), Agency for Science Technology and Research (A*STAR), Singapore., Broniowska K; Metabolon, Inc., Morrisville, North Carolina, USA., Stunkel W; Singapore Institute for Clinical Sciences (SICS), and., Takats Z; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Kinross JM; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Cruciani G; Department of Chemistry, Biology and Biotechnology, University of Perugia, Perugia, Italy., Franzoso G; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom. |
| Source: | The Journal of clinical investigation [J Clin Invest] 2021 Jun 01; Vol. 131 (11). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Print Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
